This inventor holds 2 USPTO granted patents. Top assignee: Eli Lilly and Company. Active years: 1988-1989.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile
Company Filing History:
Years Active: 1988-1989
Title: Pawel Fludzinski: Innovator in Serotonin Antagonists
Introduction
Pawel Fludzinski is a notable inventor based in Zionsville, IN (US). He has made significant contributions to the field of pharmacology, particularly in the development of serotonin antagonists. With a total of 2 patents, his work has the potential to impact various therapeutic applications.
Latest Patents
Fludzinski's latest patents include innovative compounds known as ergoline esters. These compounds are described as novel bicyclic ergoline esters useful as serotonin antagonists. His research focuses on the therapeutic potential of these compounds in treating various conditions related to serotonin pathways.
Career Highlights
Pawel Fludzinski is currently employed at Eli Lilly and Company, a leading pharmaceutical firm known for its commitment to innovation in medicine. His work at Eli Lilly has allowed him to explore and develop new therapeutic agents that can improve patient outcomes.
Collaborations
Throughout his career, Fludzinski has collaborated with esteemed colleagues such as William L. Garbrecht and Gifford P. Marzoni. These collaborations have fostered a productive environment for research and development, leading to advancements in the field.
Conclusion
Pawel Fludzinski's contributions to the field of serotonin antagonists exemplify the importance of innovation in pharmacology. His work at Eli Lilly and his patents reflect a commitment to advancing medical science and improving therapeutic options for patients.
Data source: USPTO (United States Patent and Trademark Office) public patent records. Weekly synchronization. How IDiyas builds this profile